Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug

Signal Transduct Target Ther. 2022 Aug 12;7(1):283. doi: 10.1038/s41392-022-01140-6.

Authors

Zheng Xu¹, Zhenhua Shao²

Affiliations

¹ Division of Nephrology and Kidney Research Institute, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
² Division of Nephrology and Kidney Research Institute, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China. zhenhuashao@scu.edu.cn.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Ligands
Receptors, G-Protein-Coupled* / genetics
beta-Arrestins / genetics
beta-Arrestins / metabolism

Substances

Ligands
Receptors, G-Protein-Coupled
beta-Arrestins